Date | Name | Activity | Value |
---|---|---|---|
Aug 29, 2023 | Deborah Weitzman Ceo, Pharmaceutical Segment | Sold | $602805 |
Aug 21, 2023 | Sold | $1785358 | |
Aug 17, 2023 | Sold | $288795 | |
Aug 17, 2023 | Stephen M Mason Ceo, Medical Segment | Sold | $5664578 |
Date | Firm | Activity | Value |
---|---|---|---|
Dec 31, 2023 | Bought | $202003 | |
Dec 31, 2023 | Bought | $225590 | |
Dec 31, 2023 | Bought | $226598 | |
Dec 31, 2023 | Bought | $289497 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
35,103 | Insider | ― | 3,361,463 | |
115,207 | Insider | ― | 11,032,222 | |
502,630 | Insider | ― | 48,131,849 | |
126,301 | Insider | ― | 12,094,584 | |
32,455 | Insider | ― | 3,107,891 | |
33,971 | Insider | ― | 3,253,063 | |
672,998 | Insider | ― | 64,446,288 | |
39,616 | Insider | ― | 3,793,628 | |
41,631 | Insider | ― | 3,986,585 | |
35,778 | Insider | ― | 3,426,101 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
300 | Institution | ― | 30,626 | |
514,547 | Institution | ― | 52,527,530 | |
25,144 | Institution | ― | 2,566,825 | |
503,469 | Institution | ― | 51,396,633 | |
315,233 | Institution | ― | 32,180,561 | |
51,724 | Institution | ― | 5,280,245 | |
586,277 | Institution | ― | 59,850,088 | |
25,893 | Institution | ― | 2,643,287 | |
7,629 | Institution | ― | 778,806 | |
27,361 | Institution | ― | 2,793,148 |
Holder | # of Shares | Type | % Holding | Value |
---|